ABBOTT LABORATORIES (ABT) FY2024 Q3 P&L / Income Statement

ABBOTT LABORATORIES (ABT) FY2024 Q3 P&L / Income Statement

Income statement for 2024-07-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

10,635,000,000 US dollars

Cost of products sold, excluding amortization of intangible assets

4,698,000,000 US dollars

Gross profit (calculated)

5,937,000,000 US dollars

Operating expenses (calculated)

4,078,000,000 US dollars

Operating earnings

1,859,000,000 US dollars

Other income (expense), net (calculated)

81,000,000 US dollars

Earnings before taxes

1,940,000,000 US dollars

Taxes on earnings

294,000,000 US dollars

Net Earnings

1,646,000,000 US dollars

UNITED STATES

4,202,000,000 US dollars

International

6,433,000,000 US dollars

Amortization of intangible assets

470,000,000 US dollars

Research and development

713,000,000 US dollars

Selling, general and administrative

2,895,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.